Dis-Chem Pharmacies (DCP)
Johannesburg Exchange · South Africa · prices in ZAC · close of 22 Oct 2026
Key indicators
| Last close | ZAC 2,832.00 |
|---|---|
| 52-week range | 2,535.00 – 3,900.00 |
| Return, 1 month / 3 months | +5.3% / −9.1% |
| Return, 1 year / 3 years | −15.8% / +31.5% |
| Trend | Below its 200-day average |
| RSI (14) | 61 |
| Volatility (1 year) | 25.3% |
| Worst drawdown (1 year) | -32.5% |
| Average daily value traded | 3,402.86M ZAC |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Dis-Chem Pharmacies is a South African retail pharmacy group that runs pharmacies and dispensaries across the country. It dispenses prescription medicines and sells over-the-counter remedies, health and beauty products, and household goods through its stores, serving individual shoppers and patients. The company also supplies medicines and related products to clinics and other institutional customers, and it is based in South Africa, where its outlets are concentrated in urban and suburban areas.
On this site Dis-Chem Pharmacies appears as a stock on the Johannesburg Exchange (South Africa), code DCP, with prices in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Dis-Chem Pharmacies (DCP) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 2,832.00 on 22 October 2026.
Its price-based Market X-Ray is 39 out of 100 (a weak price profile), ranking 170 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.8% and over the last three months it fell 9.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 20 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.8% | ||
| From 52-week high | -25.8% | ||
| Momentum | 16 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -9.1% | ||
| 6-month return | -24.3% | ||
| 12-month return, skipping the last month | -20.0% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 25.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.5% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 3,402.86M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +1.8% |
|---|---|
| 1 month | +5.3% |
| 3 months | −9.1% |
| 6 months | −24.3% |
| 1 year | −15.8% |
| 3 years | +31.5% |
| 5 years | −4.7% |
Signals
| 50-day / 200-day average | 2,752.84 / 3,286.22 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 79.68 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Jun 2026 | ZAC 15.9187 |
| 19 Nov 2025 | ZAC 29.4173 |
| 18 Jun 2025 | ZAC 27.8520 |
| 20 Nov 2024 | ZAC 26.9820 |
| 19 Jun 2024 | ZAC 22.4930 |
| 22 Nov 2023 | ZAC 23.2435 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.